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Abstract: Citrullination is a post-translational modification (PTM) in which positively charged
peptidyl-arginine is converted into neutral peptidyl-citrulline by peptidylarginine deiminase (PAD
or PADI) enzymes. The full protein citrullinome in many tissues is unknown. Herein, we used
mass spectrometry and identified 107 citrullinated proteins in the lactation day 9 (L9) mouse
mammary gland including histone H2A, α-tubulin, and β-casein. Given the importance of prolactin
to lactation, we next tested if it stimulates PAD-catalyzed citrullination using mouse mammary
epithelial CID-9 cells. Stimulation of CID-9 cells with 5 µg/mL prolactin for 10 min induced a
2-fold increase in histone H2A citrullination and a 4.5-fold increase in α-tubulin citrullination.
We next investigated if prolactin-induced citrullination regulates the expression of lactation genes
β-casein (Csn2) and butyrophilin (Btn1a1). Prolactin treatment for 12 h increased β-casein and
butyrophilin mRNA expression; however, this increase was significantly inhibited by the pan-PAD
inhibitor, BB-Cl-amidine (BB-ClA). We also examined the effect of tubulin citrullination on the
overall polymerization rate of microtubules. Our results show that citrullinated tubulin had a higher
maximum overall polymerization rate. Our work suggests that protein citrullination is an important
PTM that regulates gene expression and microtubule dynamics in mammary epithelial cells.
Keywords: peptidylarginine deiminase; citrullination; prolactin; mammary gland; lactation
1. Introduction
Multiple peptidylarginine deiminase (PAD or PADI) isoforms are expressed in the mammary
glands of mice, dogs, cats, and humans, primarily in luminal epithelial cells [1–3]. In dogs and mice,
PADs are expressed in lactating mammary gland secretory cells. PAD enzymes remove the positively
charged imine group from arginine residues resulting in changes in the structure, function, and
molecular interactions of substrate proteins. Histones and cytoskeletal proteins are known substrates
for PAD enzymes [4–7]. In several female reproductive tissues, PADs epigenetically regulate gene
expression via citrullination of histone tail arginine residues [2,8,9]. Cytoskeletal proteins are also targets
for citrullination, which is thought to alter filament stability and intermolecular interactions [10–12].
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Citrullinated cytoskeletal filaments are present in the synovial tissue of rheumatoid arthritis (RA)
patients and may be involved in disease progression [7,13]. In many tissues, including the mammary
gland, the normal physiological function of a majority of citrullinated proteins is unknown.
The peptide hormone prolactin (PRL), secreted from lactotrope cells in the anterior pituitary
gland, is required to initiate lactation and milk protein synthesis by mammary secretory cells. PRL
binding to its type I cytokine receptor causes receptor dimerization and activation of the Janus kinase 2
(JAK2)/signal transducer and activator of transcription 5 (STAT5) signaling pathway. Phosphorylated
STAT5a and STAT5b dimerize, translocate to the nucleus, and target interferon-γ-activated sequence
(GAS) motifs on lactation related gene promoters to induce gene transcription by mammary secretory
cells [14,15]. Prolactin stimulates robust transcription of β-casein (Csn2), a major milk protein [16,17].
Following translation, milk proteins are processed in the endoplasmic reticulum, packaged into
secretory vesicles in the Golgi apparatus, transported to the apical region of the lactating mammary
secretory cells via a microtubule networks, and then secreted into the alveoli lumen by exocytosis [17,18].
For milk lipid secretion, the small triacylglycerol-rich lipids form larger cytoplasmic lipid droplets
(CLDs) that are transported to the apical membrane of mammary secretory cells. CLDs are encapsulated
by membrane/protein complexes that are necessary for milk fat globule secretion [19,20]. Although
the molecular mechanisms mediating milk fat globule secretion are not well described, the protein
butyrophilin (Btn1a1) is essential to regulate the size of the lipid droplets secreted in milk [21].
Microtubules, composed of α- and β-tubulin heterodimers, form hollow cylindrical polymer
structures that increase from late pregnancy through lactation in the guinea pig mammary gland [22].
In mammary epithelial cells, microtubules are abundant in the apical region and orient perpendicular
to the plasma membrane [23]. Microtubules are necessary to transport milk protein vesicles to
the plasma membrane, and their disruption leads to accumulation of casein-containing vesicles in
mammary secretory cells [18,24]. Though the function of microtubules in milk lipid secretion is
not well characterized, disrupting microtubules also causes accumulation of lipid droplets within
mammary secretory cells [19,25]. Intriguingly, other post-translational modifications (PTMs) of α- and
β-tubulin such as phosphorylation and acetylation are well known to alter microtubule organization,
dynamics, and protein interactions [26]; yet, it is not known how these same parameters are affected by
tubulin citrullination.
Using liquid chromatography with tandem mass spectrometry (LC-MS/MS), we identified 107
citrullinated proteins in the lactation day 9 (L9) mouse mammary gland including histone H2A,
α-tubulin, and β-casein. Since prolactin is critical for mammary secretory cell function during lactation,
we tested if prolactin stimulates citrullination of histone H2A and α-tubulin using the mouse mammary
epithelial CID-9 cell line. Prolactin rapidly increased histone H2A and α-tubulin citrullination within
10 min. In terms of functional consequences, citrullination regulated expression of lactation genes Csn2
and Btn1a and altered the overall polymerization rates of microtubules, suggesting a role for this PTM
in both the synthesis and secretion of milk. Lastly, our work was the first to show that β-casein was
citrullinated in milk from mice and humans, raising additional interesting questions regarding the
biological significance of this understudied PTM.
2. Results
2.1. 107 Citrullinated Proteins Are Present in the Lactation Day 9 (L9) Mouse Mammary Gland
Our previous studies detected multiple citrullinated proteins in the L9 mouse mammary gland
using an anti-modified pan-citrulline Western blot; however, this method could not identify the
proteins [2]. To identify the citrullinated proteins, an L9 mouse mammary gland was excised, washed
in HEPES buffer, and homogenized. Citrullinated proteins from the L9 mouse mammary gland
lysate were labelled with biotin-phenylglyoxal (biotin-PG), which selectively modifies citrullinated
proteins. As a control, an equal concentration of L9 mouse mammary gland lysate was incubated
without biotin-PG. The biotin-PG-labelled citrullinated proteins and control proteins from the same
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L9 mammary gland lysate were enriched with streptavidin-conjugated agarose beads and eluted by
boiling in loading buffer. The samples were then electrophoresed for 10 min on a polyacrylamide
gel and stained with Coomassie blue. The resulting proteome bands were cored, trypsin digested,
and the proteins identified via LC-MS/MS, conducted by the proteomic and metabolomics core facility
at Colorado State University.
Scaffold identified 107 proteins in the L9 mouse mammary gland that were selectively isolated
with biotin-PG. These numbers are based on hits to the reverse database with a set peptide threshold
(0.1%) and a false discovery rate (FDR) of 0.08% (Figure 1A and Table S1). The distribution of the
citrullinated proteins at the biological process and subcellular level were examined using gene ontology
(GO) analysis. Sixty-four citrullinated proteins were associated with metabolic processes such as
regulation of amino acids, glucose, carbohydrates, and lipids, which suggests the potential physiological
importance of citrullinated proteins in milk production (Figure 1B). In terms of subcellular localization,
79 cytoplasmic proteins were citrullinated, 9 of which were cytoskeletal, while 40 citrullinated proteins
were nuclear (Figure 1C).
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Figure 1. One hundred seven citrullinated proteins were present in the lactation day 9 (L9) mouse
mammary gland. (A) The Venn diagram shows the number of citrullinated proteins identified with a
biotin-PG label (Cit) and without biotin-PG as the negative control (Control) in the L9 mouse mammary
gland. The pie charts depict gene ontology (GO) analysis of citrullinated protein distribution at the
biological process (B) and cellular compartment levels (C).
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Based on these results, we chose to validate the citrullination of proteins from distinct subcellular
compartments in L9 mammary glands. These proteins include histone H2A, α-tubulin, and the major
milk protein β-casein. Total citrullinated proteins were enriched with biotin-PG or with vehicle as a
negative control following the same experimental paradigm described above. Citrullinated protein
samples were examined by Western blots and probed with anti-histone H2A, α-tubulin, and β-casein
antibodies. Then, 5% of the input sample was removed prior to enrichment and served as the loading
control. Western blot analysis validated that citrullinated histone H2A, α-tubulin, and β-casein were
present in L9 mouse mammary gland (Figure 2). Still at issue is the mechanism initiating citrullination
and ultimately its effect on protein function.
Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 4 of 17 
 
Based on these results, we chose to validate the citrullination of proteins from distinct subcellular 
compartments in L9 mammary glands. These proteins include histone H2A, α-tubulin, and the major 
milk protein β-casein. Total citrullinated proteins were enriched with biotin-PG or with vehicle as a 
negative control following the same experimental paradigm described above. Citrullinated protein 
samples were examined by Western blots and probed with anti-histone H2A, α-tubulin, and β-casein 
antibodies. Then, 5% of the input sample was removed prior to enrichment and served as the loading 
control. Western blot analysis validated that citrullinated histone H2A, α-tubulin, and β-casein were 
present in L9 mouse mammary gland (Figure 2). Still at issue is the mechanism initiating citrullination 
and ultimately its effect on protein function. 
 
Figure 2. Histone H2A, α-tubulin, and β-casein were citrullinated in the L9 mouse mammary gland. 
L9 mouse mammary glands were harvested in HEPES buffer, then equal concentrations of lysate were 
labeled with biotin-PG (Cit) or without the probe as the negative control (Ctrl). Citrullinated proteins 
were enriched with streptavidin-conjugated agarose beads. Enriched citrullinated proteins were then 
subjected to Western blot analysis with anti-histone H2A, α-tubulin, or β-casein antibodies. A 5% 
input sample was collected before enrichment and served as the loading control. 
2.2. Prolactin Induces Histone H2A Citrullination in Mouse Mammary Epithelial CID-9 Cells 
We next hypothesized that prolactin stimulates histone H2A citrullination to initiate milk gene 
expression. To test our hypothesis, CID-9 mouse mammary epithelial cells, which express PADs and 
are prolactin responsive, were treated with vehicle or 5 µg/mL prolactin for 10 or 30 min. Following 
treatment, cells were lysed and equal concentrations of lysate from each time point were labeled with 
biotin-PG, while 5% input was removed prior to enrichment and served as a loading control. 
Resulting samples and 5% input controls were examined by Western blot, and membranes were 
probed with an anti-histone H2A antibody. A representative Western blot and quantification of 
multiple blots revealed that 10 min stimulation of CID-9 cells with 5 µg/mL prolactin significantly 
increased citrullination of histone H2A by greater than 2-fold (Figure 3). These results suggest that 
prolactin stimulates histone H2A citrullination; however, the genes regulated by this mechanism are 
unknown.  
Figure 2. istone 2A, α-tubulin, and β-casein ere citrullinated in the L9 ouse a ary gland.
L9 mouse mammary glands were harvested in HEPES buffer, then equal concentrations of lysate were
labeled with biotin-PG (Cit) or without the probe as the negative control (Ctrl). Citrullinated proteins
were enriched with streptavidin-conjugated agarose beads. Enriched citrullinated proteins were then
subjected to Western blot analysis with anti-histone H2A, α-tubulin, or β-casein antibodies. A 5% input
sample was collected before enrichment and served as the loading control.
2.2. Prolactin Induces Histone H2A Citrullination in Mouse Mammary Epithelial CID-9 Cells
We next hypothesized that prolactin stimulates histone H2A citrullination to initiate milk gene
expression. To test our hypothesis, CID-9 mouse mammary epithelial cells, which express PADs and
are prolactin responsive, were treated with vehicle or 5 µg/mL prolactin for 10 or 30 min. Following
treatment, cells were lysed and equal concentrations of lysate from each time point were labeled with
biotin-PG, while 5% input was removed prior to enrichment and served as a loading control. Resulting
samples and 5% input controls were examined by Western blot, and membranes were probed with an
anti-histone H2A antibody. A representative Western blot and quantification of multiple blots revealed
that 10 min stimulation of CID-9 cells with 5 µg/mL prolactin significantly increased citrullination of
histone H2A by greater than 2-fold (Figure 3). These results suggest that prolactin stimulates histone
H2A citrullination; however, the genes regulated by this mechanism are unknown.
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Figure 3. Prolactin induced histone H2A citrullination in mouse mammary epithelial CID-9 cells. CID-9
cells were treated with vehicle or 5 µg/mL prolactin for 10 and 30 in. Equal amounts of lysate from
each time point were labeled with biotin-PG and enriched with streptavidin-conjugated agarose beads.
A 5% input sample was removed before enrichment and served as the loading control. Citrullinated
histones and 5% input samples were examined by Western blot analysis, an membranes were probed
with the anti- ist H2A antibody. The to panel shows a representative Western blot, while the
bottom panel represents the quantification of multiple Western blots using BioRad Image Lab 4.0. Data
ar presented as m ans +/− SEM d separat d using ANOVA SNK (n = 3, * p < 0.05).
2.3. Prolactin Stimulates Citrullination to Increase β-Casein and Butyrophilin mRNA Expression in CID-9
Cells
Since it is well documented that histone citrulli ation alters gene expression, we ext tested if
lactation-related genes are regulated by prolactin-induced citrullination in CID-9 cells. To determine
a time course for lactation-related mRNA expression, CID-9 cells were first treated with vehicle or
5 µg/mL prolactin for 1, 6, 12, and 24 h. Following cell lysis and RNA purification, samples were
subjected to qPCR analysis with specific primers to the milk mRNAs β-casein and butyrophilin.
Results indicate that prolactin stimulation of CID-9 cells for 12 h significantly increases β-casein and
butyrophilin mRNA expression by approximately 50-fold and 2-fold, respectively, compared to vehicle
treated cells (Figure 4A). We next tested if inhibiting PAD activity blunts prolactin induced expression
of the β-casein and butyrophilin mRNA. CID-9 cells were pre-treated with DMSO or 2 µM BB-ClA for
1 h, followed by treatment with vehicle or 5 µg/mL prolactin for 12 h. While 12 h prolactin treatment
significantly increased β-casein and butyrophilin mRNA, pre-treatment of CID-9 cells with BB-ClA
significantly blocked prolactin induced expression of these mRNAs (Figure 4B). Our data suggest that
β-casein and butyrophilin expression is regulated by prolactin-induced citrullination in CID-9 cells.
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Figure 4. Inhibiting citrullination blocked prolactin induced expression of milk proteins β-casein and
butyrophilin in mouse mammary epithelial CID-9 cells. (A) CID-9 cells were treated with vehicle or
5 µg/mL prolactin for 1, 6, 12, or 24 h. Total RNA was extracted, reverse transcribed, and subjected
to qPCR performed with primers specific to Csn2 and Btn1a1 or Gapdh as the endogenous controls
(n < 4, * p < 0.05, ** p < 0.01, *** p < 0.001). (B) CID-9 cells were pre-treated with vehicle or 2 µM of
BB-ClA for 1 h, followed by 5 µg/mL prolactin treatment for 12 h. Total RNA was extracted, reverse
transcribed, and subjected to qPCR performed with primers specific to Csn2 and Btn1a1 or Gapdh as
the endogenous control (n = 3, ** p < 0.01, *** p < 0.001). Data are presented as means +/− SEM and
separated using ANOVA SNK.
2.4. Prolactin Stimulates Citrullination of α-Tubulin in CID-9 Cells
The α-tubulin was also citrullinated in L9 mouse mammary glands, and mass spectrometry
analysis revealed a high number of peptide hits. Interestingly, citrullinated tubulin is present in
synovial tissue from RA patients [27]; however, the physiological function of citrullinated tubulin
in mammary epithelial cells is unknown. Therefore, we chose to investigate if prolactin stimulates
α-tubulin citrullination in CID-9 cells. To test this, CID-9 cells were treated with vehicle or 5 µg/mL
prolactin for 10 or 30 min then harvested in HEPES buffer. Lysates were labeled with biotin-PG,
and the citrullinated proteins were enriched. Following washing and elution, citrullinated proteins
and 5% input were analyzed by Western blot, and membranes were probed with an anti-α-tubulin
antibody. A representative Western blot and quantification of multiple blots reveals that 10 min of 5
µg/mL prolactin treatment induced a significant 4.5-fold increase in α-tubulin citrullination (Figure 5).
Our result show for the first time that prolactin stimulated citrullination of α-tubulin in mammary
epithelial cells.
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Figure 5. Prolactin stimulated α-tubulin citrullination in mouse mammary epithelial CID-9 cells. CID-9
cells were treated with vehicle or 5 µg/mL prolactin for 10 and 30 min. Equal amounts of lysate from
each time point were labeled with biotin-PG and enriched with streptavidin-conjugated agarose beads.
A 5% input sample was removed before enrichment and served as the loading control. Citrullinated
histones and 5% input samples were examined by Western blot analysis, and membranes were probed
with the anti-α-tubulin antibody. The top panel shows a representative Western blot, while the bottom
panel represents the quantification of multiple Western blots using BioRad Image Lab 4.0. Data are
presented as means +/− SEM and separated using ANOVA SNK (n = 3, * p < 0.05).
2.5. Citrullination Alters Tubulin Polymerization Rates
PTMs alter the structure and function of tubulin, but the effect of citrullination has not been
described. To begin to address this interesting question, we examined the effect of PAD catalyzed
in vitro citrullination of p rified tubulin on polymerization rat s. First, 100 µgs of purified porci e
brain tubulin was incubated with vehicle ( ative), purified PAD enzym with calcium (active PAD),
or purified PAD enzyme without calcium (inactive PAD). Polymerization rates were then measured
sing a tubulin polymerization assay and active and inactive PAD tubulin samples were normalized to
rates for native tubulin [28–30]. Our results show that in vitro citrullination of tubulin increased Vmax
1.2-fold compared to control (Figure 6A). Polymerization rates of native and inactive PAD samples
were not significantly different, suggesting that tubulin citrullination, not PAD binding, is responsible
for the increased rate of polymerization. Following polymerization assays, 4 µgs of tubulin from each
sa ple (native, active PAD, inactive PAD) were labelled with biotin-PG, examined by Western blot, and
quantified using densitometry. Citrullination levels for active and inactive PAD tubulin samples were
normalized to native tubulin. Interestingly, native tubulin was citrullinate , but incubation with active
PAD enzyme increased levels by approximately 16% compared to inactive PAD controls (Figure 6B).
As expected, citrullinated tubulin levels in the native a d inactive PAD samples were not significantly
different. C llectively, our results are the first to suggest that PAD-catalyzed citrullination f tubulin
increases overall polymerization rates.
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Figure 6. Citrullination altered tubulin polymerization rates. (A) Purified porcine brain tubulin was
incubated with vehicle (native), purified PAD enzyme with calcium (active PAD), or purified PAD
enzyme without calcium (inactive PAD). Native, active PAD, and inactive PAD tubulin samples were
polymerized into microtubules and rates measured every 20 s through the entire polymerization range
until steady-state equilibrium was reached. The tubulin polymerization Vmax was calculated as the
maximum 5 min average slope of polymerization for all three samples. The active PAD and inactive
PAD Vmax values are represented as fold change compared to native tubulin Vmax. All values are
expressed as the mean ± SEM. Means were separated using Student’s t-test and * indicates significantly
different means (n = 6, * p < 0.05). (B) After completion of the polymerization assay, 4 µgs of native,
active PAD, and inactive PAD tubulin samples were labelled with biotin-PG and examined by Western
blot. The top panel shows a representative Western blot, while the bottom panel represents the
quantification of multiple Western blots using ThermoFisher iBright Analysis software. Densitometry
results for citrullinated tubulin for active PAD and inactive PAD samples were normalized to native
tubulin to allow for comparison across different experiments. Data are presented as means +/− SEM
and separated using the student Student’s t-test (n = 6, * p < 0.05).
2.6. β-Casein Is Citrullinated in Mouse and Human Milk
Mass spectrometry and subsequent validation also revealed that the milk protein β-casein was
citrullin ted in the L9 mouse mammary gland. This finding prompted us to investiga if citrullinated
β-casei is present in and human milk. Mouse milk was collected as previously described
and three ampl s were btaine fro a human milk ban [31]. Citrullin ted pr teins in milk were
labelled with biotin-PG and enriched with streptavidin conjugated agarose beads. Followi g washing
and e ution, biotin-PG-labelled cit ullinated pro eins an 5% u label input milk were analyzed
by Western blot, and membranes were probed with anti-β-casein antibodies. Our results show that
citru lination of β-casein was present and conserved between mouse and hum milk (Figure 7).
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Figure 7. β-casein was citrullinated in mouse and human milk. L9 mouse milk and three human breast
milk samples were labelled with biotin-PG (Cit) or without biotin-PG (Ctrl), enriched with streptavidin
beads, and then separated by Western blot. PVDF membranes containing enriched citrullinated proteins
were then probed with anti-β-casein antibodies. A 5% input sample was collected before enrichment
and served as the loading control.
3. Discussion
The physiological function of protein citrullination in the lactating mammary gland has not
previously been well defi ed. This is a s gnificant gap in know edge given that breast milk i the
rimary source of nutrition and mmunological protection f r newborns and sinc lactation has
nu erou health be efits for nursing mothers [32,33]. Herein, we address this gap in knowledge by
first identifying the citrullinome of the lactating mouse mammary gland and then i vestigatin the
function of specific it lli ated proteins. Although identification of different tissue citrullinomes
is increasing, our understanding of the conseq ences of this PTM on protein function remains an
importa t unresolved question.
To identify the citr llinated proteins, we used biotin-PG, which covalently interacts with the
urea group of citrulline residu s in proteins und r ac dic conditions [34]. This appro h has been
s d p eviously o identify more than 50 citrullinated proteins including vimentin, RNA helicas s,
and nucleophosmin in the HEK293T cell line and more than 150 citr lli ated proteins in RA serum
synovial fluid, and sy ovial tissue samples [7,34]. Our proteomic analysis identified 107 citrullinated
proteins including known PAD substrates uch as α-enolas and ker tins in the L9 mouse mammary
gland. We hose to validate the citrullination of histo e H2A, α-tubuli , and β-casein b cause the
have distin t subcellular localizations and functions in mammary ep thelial cells. A limitation of
our approa h is that we have identified the citrullinome fro the entire lactating mammary gland
including milk. Therefore, we cannot conclusively determine cellular orig of the citrullinate
proteins despite t fact that PADs are primarily expressed in the secret y epithelial cells of the
lactat g mouse mammary gland [1,35].
Citrullinat d histone H2A is present in L9 mouse mammary glands, and prolactin rapidly
stimula es a significant increase in histone H2A citrullination in CID-9 cells. PAD catalyzed citrullination
of histone H2A was first dentifi d in granulocyte-differenti ted HL-60 cells, where citrullination
occ rs at arginine 3 of the N-terminal sequence Ac-SGRGK [36]. In CID-9 c lls, Csn2 mRNA expression
is stimulated by 12-h prolact treatment, but it is significantly decreased following pre-treatme t
with the pan-PAD inhibi or, BB-ClA. Prolactin also stimul tes other histone modification to facilitate
β-case en expression. Kabotyanski et al. showed that prolactin stimulation recruits STAT5 and
histone deacetylase 1 (HDAC1) to the Csn2 promoter [37]. In the lacta ing mouse mammary gland
there is also en ichment of euchromatin markers such as dimethyla ed ly ine 4 histone H3 (H3K4
me2) a d histon H3 acetylation (H3Ac) on the C n2 promoter [38,39]. Given these finding , it seem
likely that prolact stimulates multiple epigenetic mod fications including histone citrullination to
upregulate Csn2 gene xpres ion. Compared to β-casein, much less s known about the expression of
butyrophili despite its imp rtant o e in milk lipid secretion. Btn1a1 mRNA expression increases
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more than 2-fold at parturition in mouse mammary gland [17]. The 5′- flanking region of the mouse
Btn1a1 promoter contains several putative STATs binding sites, suggesting a mechanism for prolactin
regulation [40]. There is currently no commercial antibody to citrullinated histone H2A. Without this
antibody, we are unable to perform chromatin immunoprecipitation to test for a direct association
between citrullinated histone H2A and the Csn2 or Btn1a1 gene promoters.
Our studies detected citrullinated α-tubulin in the lactating mouse mammary gland and show that
10 min of 5 µg/mL prolactin treatment increases citrullination of α-tubulin compared to vehicle-treated
CID-9 cells. Commercially available purified tubulin from porcine brain tissue is highly citrullinated,
indicating an important role for this PTM in vivo. To the best of our knowledge, our work is the first
to show that in vitro citrullination of tubulin alters overall polymerization kinetics. The relatively
small change in Vmax associated with in vitro citrullination of tubulin may be, in part, due to the high
endogenous level of citrullination on the native tubulin. The polymerization Vmax of native tubulin is
not significantly different in the presence of inactive PAD enzyme, suggesting that the effect is not due to
PAD binding to tubulin, but rather citrullination of tubulin. It is likely that citrullination acts in concert
with other tubulin PTMs such as acetylation, which can stabilize microtubules and promote binding
of molecular motors [26,41]. In lactating mammary epithelial cells, post-Golgi protein-containing
vesicles are transported along polymerized microtubules to the apical region of the cell for eventual
secretion [24]. Given this, it is possible that citrullination of tubulin not only alters polymerization rates,
but also directs molecular motors to traffic milk vesicles along microtubule networks. Regardless, our
work suggests that citrullination of tubulin may represent a novel mechanism to facilitate milk vesicle
secretion in lactating mammary secretory cells. To better address these intriguing questions, studies
are currently underway that will use purified human tubulin from a non-mammalian source which
lacks PAD enzymes to circumvent high endogenous levels of citrullination on purified native tubulin.
Equally intriguing, our work for the first time shows that β-casein is citrullinated in mouse and
human milk. Currently, the functional significance of this observation is unclear, but caseins contain
numerous PTMs. For example, α- and β–caseins are phosphorylated while κ-casein is glycosylated,
and these modifications are believed to be important for micelle formation and stability [42]. Micelle
structure is an important physical property of milk and provides a delivery mechanism for amino acids
and calcium for infant nutrition. Therefore, it will be very interesting to determine if citrullination of
β-casein alters micelle structure.
In conclusion, we have identified the citrullinome of the L9 mouse mammary gland and
characterized the role of citrullinated histone H2A and α-tubulin in CID-9 mouse mammary epithelial
cells. Our work shows that prolactin stimulates Csn2 and Btn1a1 expression via citrullination.
Simultaneously, prolactin stimulates citrullination of α-tubulin to potentially aid in milk secretion.
We propose a model in which PAD-catalyzed citrullination is required for both the synthesis of milk
proteins and also for transport of milk vesicles along microtubule networks. Overall, our work
advances knowledge of PAD enzyme function in the synthesis and secretion of milk components
during lactation.
4. Materials and Methods
4.1. Cell Culture and PAD Inhibitor Treatments
The CID-9 cell line was obtained from Dr. Mina Bissell and maintained as previously
described [2,43]. For prolactin treatment, CID-9 cells were grown in phenol red free DMEM (Hyclone,
Logan, UT, USA) with 2% charcoal stripped FBS (Corning, Mediatech, Manassas, VA, USA), 5 µg/mL
insulin (MilliporeSigma, Burlington, MA, USA), and 1 µg/mL hydrocortisone (MilliporeSigma) for
48 h. Cells were then treated with vehicle or 5 µg/mL prolactin (MilliporeSigma) for the designated
times. Dr. Paul Thompson synthesized and generously provided the biotin-phenylglyoxal (biotin-PG)
probe and the pan-PAD inhibitor, biphenyl-benzimidazole-Cl-amidine (BB-ClA) [34,44]. Cells were
pre-treated with vehicle or 2 µM BB-ClA for 1 h prior to prolactin treatments.
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4.2. Mouse Mammary Tissue and Human Breast Milk
FVB mice were maintained on a 12 h light/dark cycle with ad libitum access to food and water.
The abdominal mammary glands were collected from female mice on lactation day 9 as was milk.
Euthanasia was performed by CO2 asphyxiation and tissue harvested in accordance with the guidelines
outlined in the Report of the AVMA on Euthanasia. All work in this study was approved by the
University of Wyoming Institutional Animal Care and Use Committee (protocol #20140228BC00067-03,
approval 27 February 2017). De-identified human breast milk samples were obtained from the Rocky
Mountain Children’s Health Foundation Mother’s Milk Bank (Arvada, CO, USA).
4.3. Biotin-Phenylglyoxal Enrichment of Citrullinated Proteins
L9 mouse mammary glands were excised, washed 3× with PBS, and homogenized in 50 mM
cold HEPES, pH 7.6. The sample was cleared by centrifugation at 17,000× g for 15 min at 4 ◦C, and
the fat layer was removed and the step was repeated until no visible fat layer was observed. Protein
concentration was measured by BCA Assay and 300 µg of lysate was incubated with biotin-PG as
previously described [34]. Before biotin-PG enrichment, 5% of sample was removed to serve as a
loading control. The remaining sample was diluted in 200 µL of PBS containing 0.2% SDS. Then,
100 µL of high-capacity streptavidin or captavidin beads (Thermo Fisher Scientific Inc., Waltham, MA,
USA) were added to samples and rotated gently overnight at 4 ◦C. The bead–protein complexes were
washed, and then proteins eluted from the beads by boiling in loading buffer (50 µL; 125 mM Tris-HCL,
10% glycerol, 6 mM EDTA 10% SDS, 8 M urea, and 200 mM DTT) at 100 ◦C for 15 min. A similar
protocol was used to enrich citrullinated proteins from CID-9 cells and milk. Briefly, CID-9 cells were
washed with cold PBS, scraped from the plate, pelleted, and then sonicated in 50 mM cold HEPES,
pH 7.6. For CID-9 cells and human and mouse milk, protein concentration was measured by BCA
Assay and 10 µg of total protein was labeled with biotin-PG as described above. Citrullinated proteins
from CID-9 cells and human and mouse milk were examined by Western blot as described below.
4.4. LC-MS/MS Proteomics
Citrullinated and control samples were generated as described above using the same L9 mouse
mammary gland lysate. The control contained an equal concentration of lysate treated with vehicle
rather than biotin-PG. Both citrullinated and control samples were subsequently incubated with
streptavidin beads. Following enrichment, lysates were subjected to SDS-PAGE using a 10% gel
(acrylamide/bis-acrylamide ratio of 29:1) for 10 min. The gel was then stained with 200 mL Kang’s
colloidal Coomassie (0.02% CBB G-250, 5% aluminum sulfate-(14-18)-hydrate, 10% ethanol (96%), and
2% orthophosphoric acid (85%)) overnight on a shaker at room temperature [45]. The next morning,
the Coomassie solution was removed and the gel was de-stained with 200 mL destaining solution (10%
ethanol (96%) and 2% orthophosphoric acid (85%)) followed by 2 rinses with nanopure water. The
proteome bands from the L9 mammary glands and control were cored and subjected to LC-MS/MS
proteomic analysis at the Colorado State University Proteomics and Metabolomics Core Facility.
4.4.1. Sample Preparation: In-Gel Trypsin Digestion
Gel fragments were subjected to in-gel trypsin digestion and LC-MS/MS as previously
described [46]. Briefly, the gel pieces were washed with 200 µL of LC-MS-grade water (Optima
LC-MS, Thermo Fisher Scientific Inc.) for 30 s and destained with 2 × 200 µL of 50% Acetonitrile (ACN;
Optima LC-MS Grade)/50 mM Ammonium bicarbonate at 60 ◦C, with intermittent mixing. The pieces
were dehydrated with 100% ACN and allowed to air dry. Proteins were reduced and alkylated in-gel
with 25 mM DTT in 50 mM ammonium bicarbonate (60 ◦C for 20 min) and 55 mM IAA or IAH in 50 mM
ammonium bicarbonate at room temperature in the dark for 20 min. Gel pieces were then washed
with Optima water and dried. The dried gel pieces were rehydrated in 20 µL 12 ng/µL MS-grade
trypsin (Thermo Fisher Scientific Inc.)/0.01% ProteaseMAX surfactant/50 mM ammonium bicarbonate
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mixture for 10 min at room temperature, overlaid with 30 µL 0.01% ProteaseMAX surfactant/50 mM
ammonium bicarbonate, and incubated at 50 ◦C for 1 h. Extracted peptides were transferred and
the digestion halted by addition of 10% trifluoro-acetic acid to a final concentration of 0.5%. Peptide
extracts were dehydrated then resuspended in 20 µL of 5% ACN/0.1% formic acid. Once resolubilized,
absorbance at 205 nm was measured on a NanoDrop (Thermo Fisher Scientific Inc.) and total peptide
concentration was subsequently calculated using an extinction coefficient of 31 [47].
4.4.2. Mass Spectrometry Analysis
A total of ~0.85 µg of peptides were purified and concentrated using an on-line enrichment column
(Waters Symmetry Trap C18 100Å, 5 µm, 180 µm ID × 20 mm column). Subsequent chromatographic
separation was performed on a reverse phase nanospray column (Waters, Peptide BEH C18; 1.7 µm,
75 µm ID × 150 mm column, 45 ◦C) using a 90 min gradient: 5–30% buffer B over 85 min followed by
30–45%B over 5 min (B: 0.1% formic acid in ACN) at a flow rate of 350 nanoliters/min. Peptides were
eluted directly into the mass spectrometer (Orbitrap Velos, Thermo Fisher Scientific Inc.) equipped with
a Nanospray Flex ion source and spectra were collected over a m/z range of 400–2000, positive mode
ionization, using a dynamic exclusion limit of 2 MS/MS spectra of a given m/z value for 30 s (exclusion
duration of 90 s). The instrument was operated in FT mode for MS detection (resolution of 60,000) and
ion trap mode for MS/MS detection with normalized collision energy set to 35%. Compound lists of
the resulting spectra were generated using Xcalibur 3.0 software (Thermo Fisher Scientific Inc.) with
an S/N threshold of 1.5 and 1 scan/group.
4.4.3. Data Analysis
Tandem mass spectra were extracted, charge state deconvoluted, and deisotoped by ProteoWizard
MsConvert (version 3.0). Spectra from all samples were searched using Mascot (Matrix Science, London,
UK; version 2.6.0) against the Uniprot_Mouse_rev_072017 database with 119,162 entries assuming the
digestion enzyme trypsin. Mascot was searched with a fragment ion mass tolerance of 0.80 Da and a
parent ion tolerance of 20 PPM. Oxidation of methionine, carboxymethyl of cysteine, and biotin-PG
w/Cit of arginine were specified in Mascot as variable modifications. Search results from all samples
were imported and combined using the probabilistic protein identification algorithms implemented
in the Scaffold software (version Scaffold_4.8.4, Proteome Software Inc., Portland, OR, USA) [48,49].
Peptide thresholds were set (0.1%) such that a peptide FDR of 0.08% was achieved based on hits to the
reverse database [50]. Protein identifications were accepted if they could be established at greater than
99.0% probability (≤1% FDR) and contained at least two identified peptides. Protein probabilities were
assigned by the Protein Prophet algorithm [51]. Proteins that contained similar peptides and could not
be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.
4.4.4. Instrument Suitability
Instrument suitability was monitored through analysis of commercially purchased BSA standard
digest and automated monitoring using PanormaQC. Metrics (e.g., mass accuracy, peak area, retention
time, etc.) were monitored and flagged as outliers if results were outside +/− 3 standard deviations of
the guide set (i.e., optimal operation). Values for all metrics were within normal limits throughout the
duration of the experiment, indicating instrument stability and data robustness.
4.5. Western Blotting
Before biotin-PG enrichment, 5% of L9 mammary gland and CID-9 cell lysates were removed
to serve as an input loading control. Samples were subjected to SDS-PAGE using a 12% or 15% gel
(acrylamide/bis-acrylamide ratio of 29:1) and subsequently transferred to Immobilon PVDF membranes
(MilliporeSigma). Membranes were blocked in 1× casein (Vector Labs, Burlingame, CA, USA) and
diluted in Tris buffered saline containing 0.1% Tween-20 (TBS-T) overnight at 4 ◦C. Primary antibodies
were incubated overnight at 4 ◦C: anti-Histone H2A (Cell Signaling Technology, #12349, Danvers,
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MA, USA), anti-α-tubulin (Abcam, ab52866, Cambridge, MA, USA), anti-mouse β-casein (Santa Cruz
Biotechnology, sc-166530, Dallas, TX, USA), and anti-human β-casein (Abcam, ab205301) were all
diluted 1:1000 and incubated overnight at 4 ◦C. The following morning, membranes were washed in
TBS-T, followed by a 2 h incubation at room temperature with 1:10,000 goat anti-rabbit HRP (Jackson
ImmunoResearch Labs, West Grove, PA, USA) secondary antibody. All blots were washed for 50 min
(5 × 10 min) with TBS-T after secondary antibody incubation and then visualized using SuperSignal
West Pico and Femto chemiluminescence substrate (Thermo Fisher Scientific Inc.). Quantitative
densitometry analysis was conducted with Bio-Rad Image Lab software (Hercules, CA, USA).
Experiments were repeated at least three times. Means were separated using student–Newman–Keuls
(SNK) ANOVA and * indicates significantly different means p < 0.05.
4.6. qPCR
RNA was purified from CID-9 cells as previously described [2]. First, 1 µg of resulting
RNA was reverse transcribed using iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad).
Complementary DNA was subject to real time PCR analysis with SYBR Green assays (Bio-Rad)
using intron spanning primers specific for Csn2, Btn1a1, or Gapdh as the reference gene
control. Csn2 F: 5′ GCAGGCAGAGGATGTGCTC 3′, R: 5′ GAGCATATGGAAAGGCCT 3′;
Btn1a1 F: 5′ GCCGCCGTATACCTCAAA 3′, R: 5′ TCCATTCTCTTGAACCGTCA 3′; Gapdh F: 5′
GGGTTCCTATAAATACGGACTGC 3′, R: 5′ CCATTTTGTCTACGGGACGA 3′. Data were analyzed
using the delta/delta Ct method in which Ct values of all target genes are adjusted to corresponding Ct
value of reference gene Gapdh. All values are expressed as the mean ± SEM. Means were separated
using SNK ANOVA and * indicates significantly different means p < 0.05.
4.7. In Vitro Tubulin Citrullination and Polymerization
Purified porcine brain tubulin was purchased from MP Biomedicals (Irvine, CA, USA),
PurSolutions (Nashville, TN, USA), and Cytoskeleton Inc. (Denver, CO, USA). For each experiment,
four tubulin samples were prepared in duplicate: negative control, native tubulin, active PAD,
and inactive PAD. Samples were resuspended as directed except that 2 mM Ca2+ was added to all
samples to inhibit tubulin polymerization while simultaneously activating the PAD enzyme for in vitro
citrullination [28–30]. Then, 1 µL of rabbit skeletal muscle PAD enzyme (Sigma-Aldrich, St. Louis, MO,
USA) was added per 100 µg of tubulin to the active PAD sample while the rest received vehicle, and
the samples were incubated at 37 ◦C for 30 min. The negative control sample contained 1 mM Ca2+ and
served as the negative control for the polymerization assay. EGTA was added to a final concentration
of 10 mM in the native tubulin, active PAD, and inactive PAD samples. Free Ca2+ after EGTA addition
was calculated to be 0.15 µM, sufficiently low to allow for tubulin polymerization and to decrease PAD
activity by approximately 6 orders of magnitude [52,53]. After addition of EGTA, 1 µL of rabbit skeletal
muscle PAD enzyme per 100 µg tubulin was added to the inactive samples to control for PAD binding.
A tubulin polymerization assay (Cytoskeleton Inc., Denver, CO, USA) was used as previously
described [28–30]. Briefly, the polymerization reaction was initiated by transfer of negative control,
native tubulin, active PAD, and inactive PAD samples in duplicate to a fluorescence plate pre-warmed
to 37 ◦C. Polymerization was monitored at 20 s intervals on a Biotek Synergy 4 96-well fluorescence
plate reader with excitation/emission at 350 nm/450 nm. The reactions were monitored through the
nucleation, polymerization, and into steady-state equilibrium phases of microtubule polymerization.
The Vmax of microtubule formation was determined by calculating the maximum 5 min average slope
during polymerization for all samples in each experiment. Vmax values for active PAD and inactive
PAD samples were normalized to the native tubulin Vmax to allow for comparison across different
experiments. All values are expressed as the mean ± SEM. Means were separated using student’s t-test
and * indicates significantly different means p < 0.05.
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4.7.1. Citrullinated Tubulin Western Blot
Post polymerization, 4 µgs of tubulin samples were labelled with biotin-PG and electrophoresed
on polyacrylamide gel and transferred to a PVDF membrane as described above. The membrane
was then probed with DyLight 488 streptavidin (Vector Labs) to detect citrullinated tubulin. After
washing, bands were visualized on an iBright FL1500 Imager (Thermo Fisher Scientific Inc.) made
available by the Wyoming Sensory Biology COBRE award (P20GM121310) from the National Institutes
of Health. Quantitative densitometry analysis was conducted using the iBright analysis software.
Active PAD and inactive PAD samples were normalized to the native tubulin to allow for comparison
across different experiments. All values are expressed as the mean ± SEM. Means were separated
using student’s t-test and * indicates significantly different means p < 0.05.
4.7.2. Statistical Analysis
Graphs and statistical analysis was performed with GraphPad Prism 6.0 (GraphPad Software,
San Diego, CA, USA). All experiments were independently repeated at least three times and resulting
values are expressed as the mean ± SEM. Means were separated using SNK ANOVA or student’s t-test
and * indicates significantly different means * p < 0.05, ** p < 0.01, and *** p < 0.001.
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s1. Table S1. Citrullinated proteins identified by LC-MS/MS. The full list of citrullinated (cit) proteins (107),
proteins found in cit and control samples (35), and found only in control samples (7) using biotin-phenylglyoxal
enrichment of citrullinated proteins.
Author Contributions: Conceptualization, G.L., H.M.R., B.D.C.; methodology, G.L., C.H.Y., A.O.C., H.M.R.,
B.D.C.; validation, G.L., C.H.Y., A.O.C., H.M.R.; formal analysis, G.L., B.S.; investigation, G.L., C.H.Y., A.O.C.,
H.M.R., B.D.C.; resources, M.K.D., V.V.N., P.R.T.; data curation, B.D.C.; writing—original draft preparation,
G.L.; writing—review and editing, H.M.R., B.D.C.; visualization, G.L., B.S., B.D.C.; supervision, B.D.C.; project
administration, B.D.C.; funding acquisition, B.D.C. All authors have read and agreed to the published version of
the manuscript.
Funding: Research reported in this publication was supported by the National Institute of General Medical
Sciences of the National Institutes of Health under the Award Number P20GM103432 (B.D.C.) and in part by R35
GM118112 (P.R.T). The content is solely the responsibility of the authors and does not necessarily represent the
official views of the National Institutes of Health. A.O.C. was supported by the University of Wyoming Science
Initiative’s Research Scholars Program. Research was supported in part by a grant from the Center for Women’s
Health Research located at the University of Colorado Anschutz Medical Campus (M.K.D.).
Acknowledgments: The authors would like to thank Kitty Brown at the Proteomics and Metabolomics Facility at
Colorado State University for the LC-MS/MS analysis. We also would like to thank the Human Milk Banking
Association of North America for providing the human breast milk samples.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
JAK Janus kinase




CLD Cytoplasmic lipid droplet






L9 Lactation day 9
PTM Post-translational modification
Int. J. Mol. Sci. 2020, 21, 2634 15 of 17
References
1. Cherrington, B.D.; Morency, E.; Struble, A.M.; Coonrod, S.A.; Wakshlag, J.J. Potential role for peptidylarginine
deiminase 2 (pad2) in citrullination of canine mammary epithelial cell histones. PLoS ONE 2010, 5, e11768.
[CrossRef] [PubMed]
2. Li, G.; Hayward, I.N.; Jenkins, B.R.; Rothfuss, H.M.; Young, C.H.; Nevalainen, M.T.; Muth, A.; Thompson, P.R.;
Navratil, A.M.; Cherrington, B.D. Peptidylarginine deiminase 3 (pad3) is upregulated by prolactin stimulation
of cid-9 cells and expressed in the lactating mouse mammary gland. PLoS ONE 2016, 11, e0147503. [CrossRef]
[PubMed]
3. Cherrington, B.D.; Mohanan, S.; Diep, A.N.; Fleiss, R.; Sudilovsky, D.; Anguish, L.J.; Coonrod, S.A.;
Wakshlag, J.J. Comparative analysis of peptidylarginine deiminase-2 expression in canine, feline and human
mammary tumours. J. Comp. Pathol. 2012, 147, 139–146. [CrossRef] [PubMed]
4. Darrah, E.; Rosen, A.; Giles, J.T.; Andrade, F. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities
against cellular substrates: Novel insights into autoantigen selection in rheumatoid arthritis. Ann. Rheum.
Dis. 2012, 71, 92–98. [CrossRef]
5. Witalison, E.E.; Thompson, P.R.; Hofseth, L.J. Protein arginine deiminases and associated citrullination:
Physiological functions and diseases associated with dysregulation. Curr. Drug Targets 2015, 16, 700–710.
[CrossRef]
6. Badillo-Soto, M.A.; Rodriguez-Rodriguez, M.; Perez-Perez, M.E.; Daza-Benitez, L.; Bollain, Y.G.J.J.;
Carrillo-Jimenez, M.A.; Avalos-Diaz, E.; Herrera-Esparza, R. Potential protein targets of the peptidylarginine
deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible
meaning. Eur. J. Rheumatol. 2016, 3, 44–49. [CrossRef]
7. Tilvawala, R.; Nguyen, S.H.; Maurais, A.J.; Nemmara, V.V.; Nagar, M.; Salinger, A.J.; Nagpal, S.; Weerapana, E.;
Thompson, P.R. The rheumatoid arthritis-associated citrullinome. Cell Chem. Biol. 2018, 25, 691–704 e696.
[CrossRef]
8. Khan, S.A.; Edwards, B.S.; Muth, A.; Thompson, P.R.; Cherrington, B.D.; Navratil, A.M. Gnrh stimulates
peptidylarginine deiminase catalyzed histone citrullination in gonadotrope cells. Mol. Endocrinol. 2016, 30,
1081–1091. [CrossRef]
9. Young, C.H.; Rothfuss, H.M.; Gard, P.F.; Muth, A.; Thompson, P.R.; Ashley, R.L.; Cherrington, B.D.
Citrullination regulates the expression of insulin-like growth factor-binding protein 1 (igfbp1) in ovine
uterine luminal epithelial cells. Reproduction 2017, 153, 1–10. [CrossRef]
10. Jiang, Z.; Cui, Y.; Wang, L.; Zhao, Y.; Yan, S.; Chang, X. Investigating citrullinated proteins in tumour cell
lines. World J. Surg Oncol. 2013, 11, 260. [CrossRef]
11. van Beers, J.J.; Schwarte, C.M.; Stammen-Vogelzangs, J.; Oosterink, E.; Bozic, B.; Pruijn, G.J. The rheumatoid
arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein e, myeloid nuclear
differentiation antigen, and beta-actin. Arthritis Rheum. 2013, 65, 69–80. [CrossRef] [PubMed]
12. Senshu, T.; Kan, S.; Ogawa, H.; Manabe, M.; Asaga, H. Preferential deimination of keratin k1 and filaggrin
during the terminal differentiation of human epidermis. Biochem. Biophys. Res. Commun. 1996, 225, 712–719.
[CrossRef] [PubMed]
13. Wang, F.; Chen, F.F.; Gao, W.B.; Wang, H.Y.; Zhao, N.W.; Xu, M.; Gao, D.Y.; Yu, W.; Yan, X.L.; Zhao, J.N.;
et al. Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using
lc-maldi-tof/tof. Clin. Rheumatol. 2016, 35, 2185–2194. [CrossRef] [PubMed]
14. Liu, X.; Robinson, G.W.; Wagner, K.U.; Garrett, L.; Wynshaw-Boris, A.; Hennighausen, L. Stat5a is mandatory
for adult mammary gland development and lactogenesis. Genes Dev. 1997, 11, 179–186. [CrossRef]
15. Radhakrishnan, A.; Raju, R.; Tuladhar, N.; Subbannayya, T.; Thomas, J.K.; Goel, R.; Telikicherla, D.;
Palapetta, S.M.; Rahiman, B.A.; Venkatesh, D.D.; et al. A pathway map of prolactin signaling. J. Cell Commun.
Signal. 2012, 6, 169–173. [CrossRef]
16. Ball, R.K.; Friis, R.R.; Schoenenberger, C.A.; Doppler, W.; Groner, B. Prolactin regulation of beta-casein gene
expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 1988,
7, 2089–2095. [CrossRef]
17. Anderson, S.M.; Rudolph, M.C.; McManaman, J.L.; Neville, M.C. Key stages in mammary gland development.
Secretory activation in the mammary gland: It’s not just about milk protein synthesis! Breast Cancer Res. BCR
2007, 9, 204. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 2634 16 of 17
18. Nickerson, S.C.; Smith, J.J.; Keenan, T.W. Role of microtubules in milk secretion–action of colchicine on
microtubules and exocytosis of secretory vesicles in rat mammary epithelial cells. Cell Tissue Res. 1980, 207,
361–376. [CrossRef]
19. Heid, H.W.; Keenan, T.W. Intracellular origin and secretion of milk fat globules. Eur. J. Cell Biol. 2005, 84,
245–258. [CrossRef]
20. McManaman, J.L.; Neville, M.C. Mammary physiology and milk secretion. Adv. Drug Deliv. Rev. 2003, 55,
629–641. [CrossRef]
21. Ogg, S.L.; Weldon, A.K.; Dobbie, L.; Smith, A.J.; Mather, I.H. Expression of butyrophilin (btn1a1) in lactating
mammary gland is essential for the regulated secretion of milk-lipid droplets. Proc. Natl. Acad. Sci. USA
2004, 101, 10084–10089. [CrossRef] [PubMed]
22. Guerin, M.A.; Loizzi, R.F. Tubulin content and assembly states in guinea pig mammary gland during
pregnancy, lactation, and weaning. Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. 1980, 165, 50–54. [CrossRef]
[PubMed]
23. Nickerson, S.C.; Keenan, T.W. Distribution and orientation of microtubules in milk secreting epithelial cells
of rat mammary gland. Cell Tissue Res. 1979, 202, 303–312. [CrossRef] [PubMed]
24. Rennison, M.E.; Handel, S.E.; Wilde, C.J.; Burgoyne, R.D. Investigation of the role of microtubules in protein
secretion from lactating mouse mammary epithelial cells. J. Cell Sci. 1992, 102 Pt 2, 239–247.
25. Patton, S.; Stemberger, B.H.; Knudson, C.M. The supression of milk fat globule secretion by clochicine:
An effect coupled to inhibition of exocytosis. Biochim. Biophys. Acta 1977, 499, 404–410. [CrossRef]
26. Wloga, D.; Joachimiak, E.; Fabczak, H. Tubulin post-translational modifications and microtubule dynamics.
Int. J. Mol. Sci. 2017, 18, 2207. [CrossRef]
27. Chang, X.; Zhao, Y.; Wang, Y.; Chen, Y.; Yan, X. Screening citrullinated proteins in synovial tissues of
rheumatoid arthritis using 2-dimensional western blotting. J. Rheumatol. 2013, 40, 219–227. [CrossRef]
28. Tsai, A.C.; Pai, H.C.; Wang, C.Y.; Liou, J.P.; Teng, C.M.; Wang, J.C.; Pan, S.L. In vitro and in vivo anti-tumour
effects of mpt0b014, a novel derivative aroylquinoline, and in combination with erlotinib in human
non-small-cell lung cancer cells. Br. J. Pharmacol. 2014, 171, 122–133. [CrossRef]
29. Chen, C.H.; Liao, C.H.; Chang, Y.L.; Guh, J.H.; Pan, S.L.; Teng, C.M. Protopine, a novel microtubule-stabilizing
agent, causes mitotic arrest and apoptotic cell death in human hormone-refractory prostate cancer cell lines.
Cancer Lett. 2012, 315, 1–11. [CrossRef]
30. Bonne, D.; Heusele, C.; Simon, C.; Pantaloni, D. 4‘,6-diamidino-2-phenylindole, a fluorescent probe for
tubulin and microtubules. J. Biol. Chem. 1985, 260, 2819–2825.
31. Willingham, K.; McNulty, E.; Anderson, K.; Hayes-Klug, J.; Nalls, A.; Mathiason, C. Milk collection methods
for mice and reeves‘ muntjac deer. J. Vis. Exp. JoVE 2014, 89, e51007. [CrossRef] [PubMed]
32. Dieterich, C.M.; Felice, J.P.; O‘Sullivan, E.; Rasmussen, K.M. Breastfeeding and health outcomes for the
mother-infant dyad. Pediatr. Clin. N. Am. 2013, 60, 31–48. [CrossRef] [PubMed]
33. Ip, S.; Chung, M.; Raman, G.; Chew, P.; Magula, N.; DeVine, D.; Trikalinos, T.; Lau, J. Breastfeeding and
maternal and infant health outcomes in developed countries. Evid Rep. Technol Assess. (Full Rep.) 2007, 153,
1–186.
34. Lewallen, D.M.; Bicker, K.L.; Subramanian, V.; Clancy, K.W.; Slade, D.J.; Martell, J.; Dreyton, C.J.; Sokolove, J.;
Weerapana, E.; Thompson, P.R. Chemical proteomic platform to identify citrullinated proteins. ACS Chem.
Biol. 2015, 10, 2520–2528. [CrossRef] [PubMed]
35. Horibata, S.; Coonrod, S.A.; Cherrington, B.D. Role for peptidylarginine deiminase enzymes in disease and
female reproduction. J. Reprod. Dev. 2012, 58, 274–282. [CrossRef]
36. Hagiwara, T.; Hidaka, Y.; Yamada, M. Deimination of histone h2a and h4 at arginine 3 in hl-60 granulocytes.
Biochemistry 2005, 44, 5827–5834. [CrossRef]
37. Kabotyanski, E.B.; Huetter, M.; Xian, W.; Rijnkels, M.; Rosen, J.M. Integration of prolactin and glucocorticoid
signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors
and chromatin modifiers. Mol. Endocrinol. 2006, 20, 2355–2368. [CrossRef]
38. Rijnkels, M.; Kabotyanski, E.; Montazer-Torbati, M.B.; Hue Beauvais, C.; Vassetzky, Y.; Rosen, J.M.; Devinoy, E.
The epigenetic landscape of mammary gland development and functional differentiation. J. Mammary Gland
Biol. Neoplasia 2010, 15, 85–100. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 2634 17 of 17
39. Lemay, D.G.; Pollard, K.S.; Martin, W.F.; Freeman Zadrowski, C.; Hernandez, J.; Korf, I.; German, J.B.;
Rijnkels, M. From genes to milk: Genomic organization and epigenetic regulation of the mammary
transcriptome. PLoS ONE 2013, 8, e75030. [CrossRef]
40. Davey, H.W.; Ogg, S.L.; Husaini, Y.; Snell, R.G.; Korobko, I.V.; Mather, I.H.; Wilkins, R.J. Structure and
sequence of the bovine butyrophilin gene. Gene 1997, 199, 57–62. [CrossRef]
41. Wloga, D.; Gaertig, J. Post-translational modifications of microtubules. J. Cell Sci. 2010, 123, 3447–3455.
[CrossRef] [PubMed]
42. Holland, J.W. Post-translational modifications of caseins. In Milk Proteins: From Expression to Food;
Thompson, A., Ed.; Elsevier B.V.: Amsterdam, The Netherlands, 2009; pp. 107–132.
43. Schmidhauser, C.; Bissell, M.J.; Myers, C.A.; Casperson, G.F. Extracellular matrix and hormones
transcriptionally regulate bovine beta-casein 5’ sequences in stably transfected mouse mammary cells.
Proc. Natl. Acad. Sci. USA 1990, 87, 9118–9122. [CrossRef] [PubMed]
44. Knight, J.S.; Subramanian, V.; O’Dell, A.A.; Yalavarthi, S.; Zhao, W.; Smith, C.K.; Hodgin, J.B.; Thompson, P.R.;
Kaplan, M.J. Peptidylarginine deiminase inhibition disrupts net formation and protects against kidney,
skin and vascular disease in lupus-prone mrl/lpr mice. Ann. Rheum. Dis. 2015, 74, 2199–2206. [CrossRef]
[PubMed]
45. Dyballa, N.; Metzger, S. Fast and sensitive colloidal coomassie g-250 staining for proteins in polyacrylamide
gels. J. Vis. Exp. JoVE 2009, 30, e1431. [CrossRef] [PubMed]
46. Saveliev, S.V.; Woodroofe, C.C.; Sabat, G.; Adams, C.M.; Klaubert, D.; Wood, K.; Urh, M. Mass spectrometry
compatible surfactant for optimized in-gel protein digestion. Anal. Chem. 2013, 85, 907–914. [CrossRef]
[PubMed]
47. Scopes, R.K. Measurement of protein by spectrophotometry at 205 nm. Anal. Biochem. 1974, 59, 277–282.
[CrossRef]
48. Keller, A.; Nesvizhskii, A.I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of
peptide identifications made by ms/ms and database search. Anal. Chem. 2002, 74, 5383–5392. [CrossRef]
49. Searle, B.C.; Turner, M.; Nesvizhskii, A.I. Improving sensitivity by probabilistically combining results from
multiple ms/ms search methodologies. J. Proteome Res. 2008, 7, 245–253. [CrossRef]
50. Kall, L.; Storey, J.D.; MacCoss, M.J.; Noble, W.S. Assigning significance to peptides identified by tandem
mass spectrometry using decoy databases. J. Proteome Res. 2008, 7, 29–34. [CrossRef]
51. Nesvizhskii, A.I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem
mass spectrometry. Anal. Chem. 2003, 75, 4646–4658. [CrossRef]
52. Schoenmakers, T.J.; Visser, G.J.; Flik, G.; Theuvenet, A.P. Chelator: An improved method for computing
metal ion concentrations in physiological solutions. Biotechniques 1992, 12, 870–874, 876–879. [PubMed]
53. Musse, A.A.; Polverini, E.; Raijmakers, R.; Harauz, G. Kinetics of human peptidylarginine deiminase 2
(hpad2)–reduction of ca2+ dependence by phospholipids and assessment of proposed inhibition by paclitaxel
side chains. Biochem. Cell Biol. 2008, 86, 437–447. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
